Location: Montreal, Quebec, Canada
CIK: 0001274413 · Show all filings
Period: Q2 2017 (← Previous) (Next →)
Filing Date: Aug 14, 2017
Total Value: $914M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| PFE | PFIZER INC | 1,405,970 | $47.23M | 5.2% | $21.41 | +0.9% | COMMON | 717081103 |
| JNJ | JOHNSON & JOHNSON | 354,048 | $46.84M | 5.1% | $93.62 | +7.2% | COMMON | 478160104 |
| MRK | MERCK & CO INC | 729,483 | $46.75M | 5.1% | $40.49 | +14.9% | COMMON | 58933Y105 |
| NVS | NOVARTIS AG | 559,296 | $46.68M | 5.1% | $75.70 | — | SP ADR | 66987V109 |
| MDT | MEDTRONIC PLC | 398,360 | $35.35M | 3.9% | $67.64 | 0.0% | SHS | G5960L103 |
| FOLD | AMICUS THERAPEUTICS | 3,483,990 | $35.08M | 3.8% | $8.13 | -1.1% | COMMON | 03152W109 |
| — | ABIOMED INC | 229,272 | $32.85M | 3.6% | $107.42 | — | COMMON | 003654100 |
| REGN | REGENERON PHARMACEUTICALS | 62,898 | $30.89M | 3.4% | $429.17 | +1.4% | COMMON | 75886F107 |
| ACAD | ACADIA PHARMACEUTICALS | 1,098,809 | $30.65M | 3.4% | $27.79 | +7.2% | COMMON | 004225108 |
| — | CELGENE CORP | 233,768 | $30.36M | 3.3% | $101.37 | — | COMMON | 151020104 |
| — | NUVASIVE INC | 393,289 | $30.25M | 3.3% | $61.10 | — | COMMON | 670704105 |
| ACHC | ACADIA HEALTHCARE | 603,210 | $29.79M | 3.3% | $53.40 | -17.0% | COMMON | 00404A109 |
| BMRN | BIOMARIN PHARMAC INC | 313,382 | $28.46M | 3.1% | $80.35 | +13.2% | COMMON | 09061G101 |
| — | K2M GROUP HOLDINGS | 1,028,219 | $25.05M | 2.7% | $21.16 | — | COMMON | 48273J107 |
| DXCM | DEXCOM INC | 333,341 | $24.38M | 2.7% | $14.87 | +24.2% | COMMON | 252131107 |
| — | PORTOLA PHARMACEUTICALS | 422,143 | $23.71M | 2.6% | $20.71 | — | COMMON | 737010108 |
| COLL | COLLEGIUM PHARMACEUTICAL | 1,808,750 | $22.63M | 2.5% | $14.15 | -30.1% | COMMON | 19459J104 |
| — | AERIE PHARMACEUTICALS | 402,674 | $21.16M | 2.3% | $36.97 | — | COMMON | 00771V108 |
| TEVA | TEVA PHARMACEUTICAL | 602,279 | $20.01M | 2.2% | $32.09 | — | SP ADR | 881624209 |
| — | MYLAN N V | 495,804 | $19.25M | 2.1% | $38.99 | — | SHS EURO | N59465109 |
| EW | EDWARDS LIFESCIENCE | 160,380 | $18.96M | 2.1% | $31.31 | +16.6% | COMMON | 28176E108 |
| TDOC | TELADOC INC | 543,073 | $18.84M | 2.1% | $17.47 | +66.8% | COMMON | 87918A105 |
| — | ACCELERON PHARMA | 604,499 | $18.37M | 2.0% | $31.81 | — | COMMON | 00434H108 |
| — | LOXO ONCOLOGY INC | 221,795 | $17.79M | 1.9% | $64.66 | — | COMMON | 548862101 |
| — | LA JOLLA PHARMACEUTICAL | 589,959 | $17.56M | 1.9% | $29.78 | — | COMMON | 503459604 |
| ISRG | INTUITIVE SURGIC INC | 16,467 | $15.4M | 1.7% | $62.22 | +54.5% | COMMON | 46120E602 |
| EVH | EVOLENT HEALTH INC | 532,812 | $13.51M | 1.5% | $24.05 | 0.0% | COMMON | 30050B101 |
| IART | INTEGRA LIFESCIENCE | 243,998 | $13.3M | 1.5% | $40.68 | +17.4% | COMMON | 457985208 |
| — | GLOBAL BLOOD THERAPEUTICS | 452,781 | $12.38M | 1.4% | $19.19 | — | COMMON | 37890U108 |
| NBIX | NEUROCRINE BIOSCIENCES | 238,707 | $10.98M | 1.2% | $42.54 | +14.0% | COMMON | 64125C109 |
| — | NEURODERM LTD | 350,085 | $10.47M | 1.1% | $20.92 | — | ORD SHS | M74231107 |
| — | WRIGHT MED GROUP N V | 373,622 | $10.27M | 1.1% | $21.59 | — | ORD SHS | N96617118 |
| — | ENDO INTL PLC | 820,699 | $9.167M | 1.0% | $11.16 | — | SHS | G30401106 |
| — | NXSTAGE MEDICAL | 349,709 | $8.767M | 1.0% | $15.32 | — | COMMON | 67072V103 |
| — | ENVISION HEALTHCARE | 133,220 | $8.349M | 0.9% | $63.25 | — | COMMON | 29414D100 |
| PRTA | PROTHENA CORP PLC | 151,046 | $8.175M | 0.9% | $41.62 | +28.0% | SHS | G72800108 |
| IRTC | IRHYTHM TECHNOLOGIES | 185,170 | $7.868M | 0.9% | $36.42 | 0.0% | COMMON | 450056106 |
| MASI | MASIMO CORP | 73,300 | $6.683M | 0.7% | $84.91 | +8.1% | COMMON | 574795100 |
| — | DBV TECHNOLOGIES | 179,152 | $6.398M | 0.7% | $35.59 | — | SP ADR | 23306J101 |
| AGIO | AGIOS PHARMACEUTICALS | 123,599 | $6.359M | 0.7% | $49.72 | +2.8% | COMMON | 00847X104 |
| — | SPARK THERAPEUTICS | 101,300 | $6.052M | 0.7% | $59.74 | — | COMMON | 84652J103 |
| — | MOMENTA PHARMACEUTICALS | 299,400 | $5.06M | 0.6% | $11.30 | — | COMMON | 60877T100 |
| — | ALBIREO PHARMA INC | 188,712 | $3.887M | 0.4% | $20.96 | — | COMMON | 01345P106 |
| — | RA PHARMACEUTICALS | 178,750 | $3.35M | 0.4% | $15.19 | — | COMMON | 74933V108 |
| — | CLOVIS ONCOLOGY | 31,900 | $2.987M | 0.3% | $93.64 | — | COMMON | 189464100 |
| ILMN | ILLUMINA INC | 16,850 | $2.924M | 0.3% | $162.61 | +6.4% | COMMON | 452327109 |
| ARAY | ACCURAY INC | 588,347 | $2.795M | 0.3% | $5.37 | -18.2% | COMMON | 004397105 |
| INCY | INCYTE CORPORATION | 21,845 | $2.751M | 0.3% | $65.82 | +93.3% | COMMON | 45337C102 |
| — | CIGNA CORP | 15,510 | $2.596M | 0.3% | $167.38 | — | COMMON | 125509109 |
| INSM | INSMED INC | 145,799 | $2.502M | 0.3% | $14.56 | +17.3% | COMMON | 457669307 |
| — | VERSARTIS INC | 104,757 | $1.828M | 0.2% | $17.45 | — | COMMON | 92529L102 |
| — | OBSEVA SA | 212,831 | $1.82M | 0.2% | $9.21 | — | COMMON | H5861P103 |
| — | IMMUNE DESIGN CORP | 168,300 | $1.641M | 0.2% | $9.75 | — | COMMON | 45252L103 |
| — | SPRING BK PHARMACEUTICALS | 112,500 | $1.523M | 0.2% | $13.54 | — | COMMON | 849431101 |
| PTCT | PTC THERAPEUTICS I | 60,735 | $1.113M | 0.1% | $15.30 | -12.0% | COMMON | 69366J200 |
| — | SAGE THERAPEUTICS | 12,199 | $972K | 0.1% | $51.08 | — | COMMON | 78667J108 |
| SRPT | SAREPTA THERAPEUTICS | 28,799 | $971K | 0.1% | $40.16 | -18.9% | COMMON | 803607100 |
| TGTX | TG THERAPEUTICS | 81,266 | $817K | 0.1% | $7.18 | +55.9% | COMMON | 88322Q108 |
| — | TRILLIUM THERAPEUTICS | 183,272 | $806K | 0.1% | $5.35 | — | COMMON | 89620X506 |
| RDY | DR REDDYS LABS LTD | 19,065 | $803K | 0.1% | $46.18 | — | ADR | 256135203 |
| — | SIERRA ONCOLOGY INC | 201,660 | $236K | 0.0% | $1.53 | — | COMMON | 82640U107 |